Würzburger Helmholtz-Institut für RNA-basierte Infektionsforschung
Research organisation
Würzburger Helmholtz-Institut für RNA-basierte Infektionsforschung
Description
Rising antimicrobial resistance, chronic infections, and (re-) emerging pathogens are among the major challenges facing humanity. RNA is increasingly understood to contribute to key regulatory and sensory processes in the cell, but the role of RNA in infection biology remains understudied.
Research at HIRI—in the city of Würzburg, Germany—aims to close this gap by combining interdisciplinary expertise with cutting-edge research infrastructure to exploit the vast potential of RNA as a diagnostic molecule, target, and drug to combat infectious disease.
Research at HIRI—in the city of Würzburg, Germany—aims to close this gap by combining interdisciplinary expertise with cutting-edge research infrastructure to exploit the vast potential of RNA as a diagnostic molecule, target, and drug to combat infectious disease.
Würzburger Helmholtz-Institut für RNA-basierte Infektionsforschung
Address
97080 Würzburg, Germany
Contact
info@helmholtz-hiri.de
Description
Rising antimicrobial resistance, chronic infections, and (re-) emerging pathogens are among the major challenges facing humanity. RNA is increasingly understood to contribute to key regulatory and sensory processes in the cell, but the role of RNA in infection biology remains understudied.
Research at HIRI—in the city of Würzburg, Germany—aims to close this gap by combining interdisciplinary expertise with cutting-edge research infrastructure to exploit the vast potential of RNA as a diagnostic molecule, target, and drug to combat infectious disease.
Research at HIRI—in the city of Würzburg, Germany—aims to close this gap by combining interdisciplinary expertise with cutting-edge research infrastructure to exploit the vast potential of RNA as a diagnostic molecule, target, and drug to combat infectious disease.
Matchmaking
Connect with Würzburger Helmholtz-Institut für RNA-basierte Infektionsforschung
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways